Paper4348463
1 -Hydroxy derivative of vitamin D 3 : a highly potent analog of 1 ,25-dihydroxyvitamin D 3 .
Holick MF and 3 others. Science, 1973. Cited by 183 papers, by iCite.
Cite this record
ConductScience Library. 1 -Hydroxy derivative of vitamin D 3 : a highly potent analog of 1 ,25-dihydroxyvitamin D 3 . Papers, record 4348463. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/4348463
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- 1 -Hydroxy derivative of vitamin D 3 : a highly potent analog of 1 ,25-dihydroxyvitamin D 3 .
- PubMed
Topics10
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Cholecalciferol | Major topic |
| Animals | |
| Biological Assay | |
| Biological Transport | |
| Bone and Bones | |
| Calcium | |
| Intestinal Mucosa | |
| Male | |
| Rats | |
| Time Factors |
Source PubMed
Cited by23
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 183 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 36771300 | The One-Hundred-Year Anniversary of the Discovery of the Sunshine Vitamin D3: Historical, Personal Experience and Evidence-Based Perspectives. | Nutrients | 2023 | https://conductscience.org/library/papers/36771300 | PubMed |
| 35245207 | 100 YEARS OF VITAMIN D: Historical aspects of vitamin D. | Endocr Connect | 2022 | https://conductscience.org/library/papers/35245207 | PubMed |
| 34940947 | Vitamin D: Dosing, levels, form, and route of administration: Does one approach fit all? | Rev Endocr Metab Disord | 2021 | https://conductscience.org/library/papers/34940947 | PubMed |
| 25931412 | The clinical use of vitamin D metabolites and their potential developments: a position statement from the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO) and the International Osteoporosis Foundation (IOF). | Endocrine | 2015 | https://conductscience.org/library/papers/25931412 | PubMed |
| 24809324 | Alfacalcidol enhances collagen quality in ovariectomized rat bones. | J Orthop Res | 2014 | https://conductscience.org/library/papers/24809324 | PubMed |
| 19778452 | Treatment of secondary hyperparathyroidism in haemodialysis patients: a randomised clinical trial comparing paricalcitol and alfacalcidol. | BMC Nephrol | 2009 | https://conductscience.org/library/papers/19778452 | PubMed |
| 7319902 | Osteoclast formation in response to intraperitoneal injection of 1 alpha-hydroxycholecalciferol in mice. | J Anat | 1981 | https://conductscience.org/library/papers/7319902 | PubMed |
| 6775785 | Effects of 1 alpha-hydroxy vitamin D3 on the rachitic chick intestine: a comparison to the effects of 1,25-dihydroxyvitamin D3. | Calcif Tissue Int | 1980 | https://conductscience.org/library/papers/6775785 | PubMed |
| 4441974 | The effects of vitamin D analogues on bone resorption. | Calcif Tissue Res | 1974 | https://conductscience.org/library/papers/4441974 | PubMed |
| 4372612 | Vitamin D: concerning the relationship between molecular topology and biological function. | Proc Natl Acad Sci U S A | 1974 | https://conductscience.org/library/papers/4372612 | PubMed |
| 4365934 | Metabolism and action of the hormone vitamin D. Its relation to diseases of calcium homeostasis. | West J Med | 1974 | https://conductscience.org/library/papers/4365934 | PubMed |
| 4365368 | Biological activity of 1alpha-hydroxycholecalciferol, a synthetic analog of the hormonal form of vitamin D3. | Proc Natl Acad Sci U S A | 1973 | https://conductscience.org/library/papers/4365368 | PubMed |
| 3093033 | Treatment of psoriasis vulgaris by oral administration of 1 alpha-hydroxyvitamin D3--open-design study. | Calcif Tissue Int | 1986 | https://conductscience.org/library/papers/3093033 | PubMed |
| 1120218 | I alpha-hydroxycholecalciferol: a treatment of renal bone disease. | Br Med J | 1975 | https://conductscience.org/library/papers/1120218 | PubMed |
| 1054498 | Demonstration of the rapid action of pure crystalline 1 alpha-hydroxy vitamin D3 and 1 alpha,25-dihydroxy vitamin D3 on intestinal calcium uptake. | Proc Natl Acad Sci U S A | 1975 | https://conductscience.org/library/papers/1054498 | PubMed |
| 953800 | The effects of hydroxylated derivatives of vitamin D3 and of extracts of solanum malacoxylon on the absorption of calcium, phosphate and water from the jejunum of pigs. | Calcif Tissue Res | 1976 | https://conductscience.org/library/papers/953800 | PubMed |
| 953798 | The metabolism and function of 1alpha-hydroxyvitamin D3. | Calcif Tissue Res | 1976 | https://conductscience.org/library/papers/953798 | PubMed |
| 947957 | Jejunal and ileal absorption in patients with chronic renal disease. Effect of 1alpha-hydroxycholecalciferol. | J Clin Invest | 1976 | https://conductscience.org/library/papers/947957 | PubMed |
| 932193 | Comparison of effects of 1 alpha-hydroxy-vitamin D3 and 1,25-dihydroxy-vitamin D3 in man. | J Clin Invest | 1976 | https://conductscience.org/library/papers/932193 | PubMed |
| 912555 | The effects of 1alpha-OH cholecalciferol on calcium, magnesium and phosphorus metabolism in dairy heifers, and its potential value for the prevention of milk fever. | Calcif Tissue Res | 1977 | https://conductscience.org/library/papers/912555 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/4348463
GET https://conductscience.org/api/papers/v1/4348463/cited_by?page=2